Showing results (911-920 of 1,376) with videos related to
Sort By:
Pageof 138
Drug Development Research|February 27, 2025
Multifunctional Docetaxel Cholesterol-Polyethylene Glycol Co-Modified Poly (N-Butyl) Cyanoacrylate Nanoparticles for Brain Tumor TherapyXiao Hu, Feifei Yang, Yonghong Liao, et al.Drug Development Research|February 23, 2025
New Chlorophenyl Dioxo-Imidazolidines for Bacterial BiofilmShanmugha Samy, Manikandan Alagumuthu, Ooha Dharani Yalamaddi, et al.Drug Development Research|January 27, 2025
Isoliquiritigenin Protects Against Diabetic Nephropathy in db/db Mice by Inhibiting Advanced Glycation End Product-Receptor for Advanced Glycation End Product AxisQiwen Shi, Tao Zhou, Wenjun Hou, et al.Drug Development Research|January 20, 2025
Downregulation of LncRNA CCAT1 Enhances Chemosensitivity in Cisplatin-Resistant Gastric Cancer CellsQiong Wu, Chenglou Zhu, Tiantian Zhao, et al.Drug Development Research|January 31, 2025
Andrographolide Mitigates Cisplatin Resistance by Inhibiting SPP1 Regulated NF-kB/iNOS/COX-2 and PI3K/AKT Pathway in Cisplatin Resistant Cervical Carcinoma CellsAkbar Pasha, Doneti Ravinder, Smita C PawarDrug Development Research|February 6, 2025
Design, Synthesis and Molecular Docking of New Thieno[2,3‑d]Pyrimidin-4-One Derivatives as Dual EGFR and FGFR InhibitorsSara Sultan, Samar S Tawfik, Khalid B Selim, et al.Drug Development Research|February 10, 2025
Unraveling the Role of Repurposed Drugs in the Treatment of Acne: Success so Far and the Road AheadPopat S Kumbhar, Vikas Kamble, Kaustubh Ajit Kolekar, et al.Drug Development Research|November 21, 2024
Design, Synthesis, and Biological Activities Evaluation of Type I FLT3 Inhibitors for the Treatment of Acute Myeloid LeukemiaJin Yang, Yan Zhang, Yue-Chu Li, et al.Drug Development Research|December 2, 2024
Improving the Biopharmaceutical Properties of Cannabinoids in Glioblastoma Multiforme Therapy With Nanotechnology: A Drug Delivery PerspectiveStephanie B Walker, Jonatas L Duarte, Leonardo D Di Filippo, et al.Drug Development Research|March 21, 2025
Novel Benzosuberone/Indanone-Linked Thiazoles as Small-Molecule SARS-CoV-2 Main Protease InhibitorsThoraya A Farghaly, Elham N Bifari, Mariam A Al-Sheikh, et al.Pageof 138